Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.
Nat Commun. 2023 Aug 18;14(1):5032. doi: 10.1038/s41467-023-40758-0.
Nat Commun. 2023.
PMID: 37596280
Free PMC article.
Clinical Trial.
Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine Repertoires.
Grunert C, Willimsky G, Peuker CA, Rhein S, Hansmann L, Blankenstein T, Blanc E, Beule D, Keller U, Pezzutto A, Busse A.
Grunert C, et al. Among authors: peuker ca.
Cancers (Basel). 2022 Apr 6;14(7):1842. doi: 10.3390/cancers14071842.
Cancers (Basel). 2022.
PMID: 35406613
Free PMC article.
Item in Clipboard
Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial.
Peuker CA, Yaghobramzi S, Grunert C, Keilholz L, Gjerga E, Hennig S, Schaper S, Na IK, Keller U, Brucker S, Decker T, Fasching P, Fehm T, Janni W, Kümmel S, Schneeweiss A, Schuler M, Lüftner D, Busse A.
Peuker CA, et al.
Eur J Cancer. 2022 Feb;162:45-55. doi: 10.1016/j.ejca.2021.11.025. Epub 2021 Dec 23.
Eur J Cancer. 2022.
PMID: 34953442
Item in Clipboard
High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies.
Çınar Ö, Brzezicha B, Grunert C, Kloetzel PM, Beier C, Peuker CA, Keller U, Pezzutto A, Busse A.
Çınar Ö, et al. Among authors: peuker ca.
J Immunother Cancer. 2021 Jul;9(7):e002410. doi: 10.1136/jitc-2021-002410.
J Immunother Cancer. 2021.
PMID: 34330762
Free PMC article.
Item in Clipboard
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years.
Rieger K, De Filippi R, Lindén O, Viardot A, Hess G, Lerch K, Neumeister P, Stroux A, Peuker CA, Pezzutto A, Pinto A, Keller U, Scholz CW.
Rieger K, et al. Among authors: peuker ca.
Ann Hematol. 2022 Apr;101(4):781-788. doi: 10.1007/s00277-022-04781-3. Epub 2022 Feb 12.
Ann Hematol. 2022.
PMID: 35150296
Free PMC article.
Item in Clipboard
Investigation of spleen CXCR4 expression by [68Ga]Pentixafor PET in a cohort of 145 solid cancer patients.
Lewis R, Habringer S, Kircher M, Hefter M, Peuker CA, Werner R, Ademaj-Kospiri V, Gäble A, Weber W, Wester HJ, Buck A, Herhaus P, Lapa C, Keller U.
Lewis R, et al. Among authors: peuker ca.
EJNMMI Res. 2021 Aug 21;11(1):77. doi: 10.1186/s13550-021-00822-6.
EJNMMI Res. 2021.
PMID: 34417915
Free PMC article.
Item in Clipboard
Cite
Cite